Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil) — De Clercq Erik (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
Shared by
De Clercq Erik
KU Leuven
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
Article
2009
en
Related publications
Article
2003
The bicyclam AMD3100 story
De Clercq Erik
Article
2010
Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers
De Clercq Erik
Authors
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2019
Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
De Clercq Erik
Article
2008
Autophagic cell death: the story of a misnomer
Guido Guido Kroemer
,
Beth Levine
Article
2017
Unravelling the path to create a cell sheet-based model of skin scar-like tissue
Helena R. Moreira
,
Daniel B. Rodrigues
,
Rui L Reis
,
Alexandra P. Marques
Discussion(0)
No comments yet. Be the first to comment.